Literature DB >> 22539624

Dietary fat is a lipid source in 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice.

Michelle Manente Angrish1, Bryan David Mets, Arthur Daniel Jones, Timothy Richard Zacharewski.   

Abstract

2,3,7,8-Tetrachlorodibenzo-ρ-dioxin (TCDD) increases fatty acid (FA) transport and FA levels resulting in hepatic steatosis in mice. Diet as a source of lipids was investigated using customized diets, stearoyl-CoA desaturase 1 (Scd1) null mice, and (14)C-oleate (18:1n9) uptake studies. C57BL/6 mice fed with 5, 10, or 15% fat or 50, 60 or 70% carbohydrate diets exhibited increased relative liver weight following gavage with 30 µg/kg TCDD for 168 h. Hepatic lipid extract analysis from mice fed with 5, 10, and 15% fat diets identified a dose-dependent increase in total FAs induced by TCDD. Mice fed with fat diet also exhibited a dose-dependent increase in the dietary essential linoleic (18:2n6) and α-linolenic (18:3n3) acids. No dose-dependent FA increase was detected on carbohydrate diets, suggesting dietary fat as a source of lipids in TCDD-induced steatosis as opposed to de novo lipogenesis. TCDD also induced oleate levels threefold in Scd1 null mice that are incapable of desaturating stearate (18:0). This is consistent with oleate representing > 90% of all monounsaturated FAs in rodent chow. Moreover, TCDD increased hepatic (14)C-oleate levels twofold in wild type and 2.4-fold in Scd1 null mice concurrent with the induction of intestinal and hepatic lipid transport genes (Slc27a, Fabp, Ldlr, Cd36, and Apob). In addition, computational scanning identified putative dioxin response elements and in vivo ChIP-chip analysis revealed regions of aryl hydrocarbon receptor (AhR) enrichment in lipid transport genes differentially regulated by TCDD. Collectively, these results suggest the AhR mediates increased uptake of dietary fats that contribute to TCDD-elicited hepatic steatosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539624      PMCID: PMC3493189          DOI: 10.1093/toxsci/kfs155

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  50 in total

1.  Hexokinase isoenzymes in normal and cirrhotic human liver: suppression of glucokinase in cirrhosis.

Authors:  W Lowes; M Walker; K G Alberti; L Agius
Journal:  Biochim Biophys Acta       Date:  1998-01-08

2.  Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver.

Authors:  Agnes L Forgacs; Michael N Kent; Meghan K Makley; Bryan Mets; Nicholas DelRaso; Gary L Jahns; Lyle D Burgoon; Timothy R Zacharewski; Nicholas V Reo
Journal:  Toxicol Sci       Date:  2011-09-29       Impact factor: 4.849

3.  Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice.

Authors:  Shawn C Burgess; Teresa C Leone; Adam R Wende; Michelle A Croce; Zhouji Chen; A Dean Sherry; Craig R Malloy; Brian N Finck
Journal:  J Biol Chem       Date:  2006-05-02       Impact factor: 5.157

4.  Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis.

Authors:  Michelle M Angrish; A D Jones; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2011-09-02       Impact factor: 4.849

5.  Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity.

Authors:  Iain A Murray; Jose L Morales; Colin A Flaveny; Brett C Dinatale; Chris Chiaro; Krishnegowda Gowdahalli; Shantu Amin; Gary H Perdew
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

6.  Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on de novo fatty acid and cholesterol synthesis in the rat.

Authors:  M R Lakshman; B S Campbell; S J Chirtel; N Ekarohita
Journal:  Lipids       Date:  1988-09       Impact factor: 1.880

7.  Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid profiles in tissue of the Fischer rat.

Authors:  P W Albro; J T Corbett; M Harris; L D Lawson
Journal:  Chem Biol Interact       Date:  1978-12       Impact factor: 5.192

8.  Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice.

Authors:  Eric D Labonté; Lisa M Camarota; Juan C Rojas; Ronald J Jandacek; Dean E Gilham; Joanna P Davies; Yiannis A Ioannou; Patrick Tso; David Y Hui; Philip N Howles
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-21       Impact factor: 4.052

9.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

10.  Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis.

Authors:  D L Alexander; L G Ganem; P Fernandez-Salguero; F Gonzalez; C R Jefcoate
Journal:  J Cell Sci       Date:  1998-11       Impact factor: 5.285

View more
  27 in total

Review 1.  Mechanisms of Environmental Contributions to Fatty Liver Disease.

Authors:  Banrida Wahlang; Jian Jin; Juliane I Beier; Josiah E Hardesty; Erica F Daly; Regina D Schnegelberger; K Cameron Falkner; Russell A Prough; Irina A Kirpich; Matthew C Cave
Journal:  Curr Environ Health Rep       Date:  2019-09

2.  Comparison of TCDD-elicited genome-wide hepatic gene expression in Sprague-Dawley rats and C57BL/6 mice.

Authors:  Rance Nault; Suntae Kim; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-11       Impact factor: 4.219

3.  Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice.

Authors:  Shigeyuki Uno; Daniel W Nebert; Makoto Makishima
Journal:  Food Chem Toxicol       Date:  2018-01-31       Impact factor: 6.023

4.  Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis.

Authors:  Melissa M Heintz; Ramiya Kumar; Meredith M Rutledge; William S Baldwin
Journal:  J Nutr Biochem       Date:  2019-05-21       Impact factor: 6.048

5.  Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes.

Authors:  Hongxue Shi; Jian Jan; Josiah E Hardesty; K Cameron Falkner; Russell A Prough; Appakalai N Balamurugan; Sri Prakash Mokshagundam; Suresh T Chari; Matthew C Cave
Journal:  Toxicol Appl Pharmacol       Date:  2018-10-09       Impact factor: 4.219

6.  TCDD-elicited effects on liver, serum, and adipose lipid composition in C57BL/6 mice.

Authors:  Michelle Manente Angrish; Claudia Yvette Dominici; Timothy Richard Zacharewski
Journal:  Toxicol Sci       Date:  2012-09-13       Impact factor: 4.849

7.  2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice.

Authors:  Kelly A Fader; Rance Nault; Dustin A Ammendolia; Jack R Harkema; Kurt J Williams; Robert B Crawford; Norbert E Kaminski; Dave Potter; Bonnie Sharratt; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2015-09-16       Impact factor: 4.849

8.  Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity.

Authors:  Jian Jin; Banrida Wahlang; Hongxue Shi; Josiah E Hardesty; K Cameron Falkner; Kimberly Z Head; Sudhir Srivastava; Michael L Merchant; Shesh N Rai; Matthew C Cave; Russell A Prough
Journal:  Med Chem Res       Date:  2020-06-07       Impact factor: 1.965

9.  Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease.

Authors:  Banrida Wahlang; Ming Song; Juliane I Beier; K Cameron Falkner; Laila Al-Eryani; Heather B Clair; Russell A Prough; Tanasa S Osborne; David E Malarkey; J Christopher States; Matthew C Cave
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-03       Impact factor: 4.219

10.  Toxicogenomic evaluation of long-term hepatic effects of TCDD in immature, ovariectomized C57BL/6 mice.

Authors:  Anna K Kopec; Darrell R Boverhof; Rance Nault; Jack R Harkema; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Brock Chittim; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2013-07-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.